Article Text

other Versions

PDF
Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer
  1. Armando Gamboa-Dominguez (agamboad{at}quetzal.innsz.mx)
  1. Department of Pathology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico
    1. Stefan Seidl (stefan.seidl{at}lrz.tu-muenchen.de)
    1. Technische Universität München, Institut für Allgemeine Pathologie und Pathologische, Germany
      1. Edgardo Reyes-Gutierrez (guisbato{at}prodigy.net.mx)
      1. Department of Pathology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico
        1. Christine Hermannstädter (chrischie75{at}web.de)
        1. Technische Universität München, Institut für Allgemeine Pathologie und Pathologische, Germany
          1. Leticia Quintanilla-Martinez (quintanilla-fend{at}gsf.de)
          1. GSF-Forschungszentrum für Umwelt und Gesundheit, Institut für Pathologie, Neuherberg, Germany
            1. Raymonde Busch (raymonde.busch{at}imse.med.tu-muenchen.de)
            1. Technische Universität München, Institut für Medizinische Statistik und Epidemiologie, Germany
              1. Heinz Höfler (hoefler{at}lrz.tu-muenchen.de)
              1. Technische Universität München, Institut für Allgemeine Pathologie und Pathologische, Germany
                1. Falko Fend (fend{at}lrz.tu-muenchen.de)
                1. Technische Universität München, Institut für Allgemeine Pathologie und Pathologische, Germany
                  1. Birgit Luber (luber{at}lrz.tu-muenchen.de)
                  1. Technische Universität München, Institut für Allgemeine Pathologie und Pathologische, Germany

                    Abstract

                    Background: Gastric carcinoma is characterized by numerous genetic and epigenetic alterations that influence cell cycle progression, apoptosis, and DNA repair. These alterations include down-regulation of the cyclin-dependent kinase (CDK) inhibitors p21WAF1/CIP1 and p27Kip1, and mutations of the tumor suppressor protein p53 and the cell adhesion molecule E-cadherin. Combined evaluation of the prognostic significance of these alterations has not been reported in Mexican Mestizo patients so far.

                    Aims: The aim of the study was a combined evaluation of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin protein expression, including mutant E-cadherin variants with deletion of exon 8 (del 8) or 9 (del 9), in gastric cancer from Mexican patients.

                    Methods: Immunohistochemistry for the above-mentioned markers including mutation-specific E-cadherin antibodies was carried out in 69 gastric carcinomas and expression levels were correlated with histotype, tumor stage, and prognosis.

                    Results: Expression of p21WAF1/CIP1 alone or in combination with p27Kip1 or in the absence of p53 was associated with favourable prognosis. Staining of del 8 and del 9 E-cadherin was found exclusively in patients negative for p53 and positive for p21WAF1/CIP1, suggesting that the p21WAF1/CIP1 regulatory function of p53 was intact.

                    Conclusion: Combined evaluation of the prognostic significance of cell cycle regulators and E-cadherin should be performed. Even though patients negative for p53 and positive for p21WAF1/CIP1 have a favourable prognosis, it may have a negative influence on prognosis if they acquire in addition E-cadherin mutations which have been shown previously to be associated with poor survival.

                    • E-cadherin
                    • Gastric cancer
                    • p21WAF1/CIP1
                    • p27Kip1
                    • p53

                    Statistics from Altmetric.com

                    Request permissions

                    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.